OriginalDrugs

Herpes Antiviral Medications

What is Herpes?

Herpes is an infection caused by herpes simplex virus. Herpes is caused by two viruses: herpes simplex virus type 1 (HSV-1), and herpes simplex virus type 2 (HSV-2).

HSV-1 virus usually is responsible for oral infections (cold sores), and can be transmitted through oral secretions. HSV-2 virus causes the majority of genital herpes cases and can be transmitted through oral or genital secretions.

However, lesion location does not necessarily indicate the type of virus.

Cold sores

Oral herpes (also called cold sores or fever blisters) is usually caused by herpes simplex virus 1. It usually affects the lips or mucous membranes in the mouth. Sometimes blisters appear in the nose and on cheeks.

Genital herpes

Genital herpes is a chronic, life-long sexually transmitted infection. It is caused by the herpes simplex viruses type 1 (HSV-1) or type 2 (HSV-2). Most genital herpes is caused by HSV-2.

Medications for herpes infections

Currently, there is no cure for herpes. However, there are three antiviral medications approved by the Food and Drug Administration (FDA) for the treatment of herpes: acyclovir (Zovirax), famciclovir (Famvir) and valacyclovir (Valtrex). In the US antiviral medications are only available by prescription.

Antiviral medications are used to prevent or treat herpes infections, they stop the growth of the herpes simplex virus. Antiviral medications may significantly lessen the severity of a primary outbreak and reduce the time it takes for genital herpes outbreaks to heal. The medication also decreases the number of days of painful symptoms and for some people, the number of days they can spread the virus.

According to the research data, the effectiveness of the acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex) is equal. These drugs differ in their chemical structure, dosage regimen, cost and FDA licensed indications.

How do herpes antivirals work?

All three drugs disrupt the process by which the virus makes copies of itself and spreads to new cells. They do this by inhibiting an enzyme that the virus has but human cells do not and then interrupting the viruses' ability to synthesize DNA. None of the medicines cures the viral infection. Herpes virus will remain dormant in the body in the nerve ganglia.

Effectiveness of antiviral medications

  • Initial outbreak
    Antiviral medications may significantly lessen the severity of a primary outbreak and reduce the time it takes genital sores to heal.
  • Recurrent outbreaks
    Antivirals decrease the duration (on average for 1 to 2 days) and severity of recurrent genital herpes outbreaks.
  • Suppressive therapy
    Antiviral medicines are used as daily suppressive therapy to help reduce the frequency and duration of recurrent outbreaks (more than 6 recurrences a year). Antiviral medication can reduce the number of outbreaks by 70% to 80%. For most people suffering from frequent outbreaks this means no sores, pain, and discomfort.
  • Prevention of transmission
    Daily Valtrex (valaciclovir) can reduce the sexual transmission of genital herpes.
  • Reduce viral shedding
    Antiviral drugs suppress symptomatic and asymptomatic viral shedding, and reduce frequency of herpes virus reactivation. These medications have been shown in clinical trials to reduce asymptomatic herpes virus shedding by about 80-90%.

Disadvantages of antiviral medications

  • Don't eradicate latent herpes virus, and as a result don't cure the infection
  • Don't reduce the risk, frequency, or severity of herpes outbreaks after the drug is discontinued.

Acyclovir (Zovirax)

The discovery of acyclovir was important breakthrough in medicine. Acyclovir, the first successful synthetic nucleoside analogue, was originally licensed in 1982 for the treatment of herpes and marketed under the brand name Zovirax®. Now this medicine is available as a generic from many manufacturers and is by far the cheapest of the available antiviral drugs.

Acyclovir is a safe and extremely well-tolerated drug.

The Acyclovir in Pregnancy Registry has documented prenatal exposures in more than 850 women (with 578 first-trimester exposures) without any adverse outcomes. However, the total number of pregnancies monitored to-date may not be enough to detect defects that occur only infrequently.

The topical form of acyclovir (Zovirax ointment) offers little benefit in the treatment of genital herpes and is not recommended. Zovirax ointment is used for the treatment of cold sores.

Valacyclovir (Valtrex)

Valacyclovir, a new antiviral agent, is a prodrug converted to acyclovir in the intestine and liver. It has an oral bioavailability three to five times greater than that of acyclovir, allowing less frequent dosage regimen.

Valtrex (Valacyclovir) has the advantage of once-daily dosing.

Valtrex, when taken daily (suppressive therapy) by a person with recurrent genital herpes, can reduce the risk of transmission to a partner. According to the scientific research3, valaciclovir (500 mg taken once daily) significantly reduces the rate of virus transmission:

  • Symptomatic genital herpes by 75%
  • HSV-2 infection at any one time by 48%
  • Total herpes virus acquisitions by 61%

Famciclovir (Famvir)

Famciclovir (Famvir), another new antiviral medication, is the oral form of penciclovir, a purine analog similar to acyclovir. The drug is quickly converted to its active form. Mechanism and efficacy are similar to those of acyclovir.

Famciclovir is effective for both episodic and suppressive therapy of genital herpes. Different dosages are used for different treatment goals.

Famciclovir, despite its favorable intracellular pharmacokinetics, must be given twice daily to be effective.

Animal studies4 found that famciclovir (Famvir) is superior to valacyclovir (Valtrex) in reducing the establishment of HSV-1 latent infection.

Safety issues

A large volume of research suggests that the medications are safe and have few or no side effects. These medications have never been noted to cause any long-term side effects.

All three antivirals are categorized as Pregnancy Category B.

All these drugs can have renal toxicity, and their dosage schedules must be reduced in patients with renal failure.

  Zovirax GlaxoSmithKline Valtrex GlaxoSmithKline Famvir Novartis
  Acyclovir (Zovirax®) Valacyclovir (Valtrex®) Famciclovir (Famvir®)
Pharmaceutical
Forms
200 mg, 400 mg, 800 mg tablets
oral, injected, and topical
500 mg, 1000 mg caplets 125 mg, 250 mg, 500 mg tablets
Activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2)
varicella-zoster virus (VZV)
herpes simplex virus types 1 (HSV-1) and 2 (HSV-2)
varicella-zoster virus (VZV)
herpes simplex virus types 1 (HSV-1) and 2 (HSV-2)
varicella-zoster virus (VZV)
FDA approved indications
  • treatment of initial genital herpes
  • treatment of recurrent genital herpes
  • chronic suppressive therapy for recurrent genital herpes
  • acute treatment of herpes zoster (shingles)
  • treatment of chickenpox (varicella)
  • treatment of initial genital herpes
  • treatment of recurrent genital herpes
  • chronic suppressive therapy for recurrent genital herpes
  • reduction of transmission
  • treatment of herpes zoster (shingles)
  • treatment of cold sores
  • treatment of recurrent genital herpes
  • chronic suppressive therapy for recurrent genital herpes
  • treatment of acute herpes zoster (shingles)
Most common
side effects
nausea
vomiting
diarrhea
headache
nausea
vomiting
dizziness
abdominal pain
headache
nausea
diarrhea
fatigue
abdominal pain
Less common
side effects
headache
malaise
renal failure
dysmenorrhea
arthralgia
renal failure
vomiting
dysmenorrhea
flatulence
migraine
renal failure
Bioavailability 10% - 20% 55% 77%
Major route of elimination Mainly renally excreted unchanged Renal Renally excreted
Pregnancy Pregnancy Category B Pregnancy Category B Pregnancy Category B
Generic avalability Yes No No

References

  • 1. Genital Herpes STD information from CDC
  • 2. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. New England Journal of Medicine. 2004 Jan 1;350(1):11-20
  • 3. Corey L, Ashley R; Valaciclovir HSV Transmission Study Group. Prevention of herpes simplex virus type 2 transmission with antiviral therapy. Herpes. 2004 Aug;11 Suppl 3:170A-174A. Herpes (PDF format)
  • 4. Thackray AM, Field HJ. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. Antimicrobial Agents and Chemotherapy. 1998 Jul;42(7):1555-62

Last updated: September, 2009

Interesting Facts

medications
  • About 50-80% of the adult population in the United States have oral herpes.
  • About one in five adults in the United States has genital herpes. However, almost 90% of these infected people don't know they have herpes virus.
  • Herpes simplex virus enters the body through abraded skin or intact mucous membranes. Neural tissue transport results in life-long latent infection.
  • Asymptomatic shedding of herpes virus turns many infected persons into unwitting transmitters of HSV.
  • The rate of asymptomatic shedding appears to go down with time.